Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypnotic drugs for 1984.

I Oswald

    Psychopharmacology. Supplementum
    |January 1, 1984
    PubMed
    Summary

    Hypnotics and anti-anxiety drugs are the same, with regular use causing withdrawal symptoms like insomnia. Future hypnotics may focus on improving sleep quality and patient satisfaction rather than just duration.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Five Weeks to Escape the Sleeping-pill Habit.

    British medical journal·2010
    Same author

    Influence of administration route on the biotransformation of amoxicillin in the pig.

    Journal of veterinary pharmacology and therapeutics·2009
    Same author

    Two isostructural triboluminescent lanthanide complexes.

    Acta crystallographica. Section C, Crystal structure communications·2000
    Same author

    Inhibitory activity of anti-interleukin-4 and anti-interleukin-10 antibodies on Toxoplasma gondii proliferation in mouse peritoneal macrophages cocultured with splenocytes from infected mice.

    Parasitology research·2000
    Same author

    Whose data are they anyway? Access to raw data would need legislation.

    BMJ (Clinical research ed.)·1997
    Same author

    Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity.

    Journal of immunology (Baltimore, Md. : 1950)·1995

    Area of Science:

    • Pharmacology
    • Sleep Medicine
    • Psychiatry

    Background:

    • Hypnotics and anti-anxiety medications are pharmacologically similar.
    • Regular use of these drugs can lead to withdrawal phenomena, including insomnia and anxiety.

    Purpose of the Study:

    • To highlight the shared nature of hypnotics and anti-anxiety drugs.
    • To discuss withdrawal phenomena associated with different drug half-lives.
    • To explore future directions for hypnotic drug development.

    Main Methods:

    • Review of existing literature on hypnotic and anti-anxiety drug mechanisms.
    • Analysis of withdrawal patterns based on drug half-life (long-acting vs. short-acting).
    • Discussion of tolerance development and sustained effects of benzodiazepines.

    Main Results:

    • Long-acting drugs (e.g., phenobarbitone) cause gradual withdrawal and daytime impairment.
    • Short-acting drugs (e.g., triazolam) can cause severe withdrawal insomnia, especially in the elderly.
    • A 10-hour half-life may offer a balance, but withdrawal is unavoidable.

    Conclusions:

    • The choice of hypnotic drug impacts withdrawal severity and daytime side effects.
    • Future hypnotics should aim to enhance sleep's restorative value and patient satisfaction, not just duration.

    Related Experiment Videos